Concepedia

Author

Christopher-Michael Gale

Dana-Farber Cancer Institute

Also Known As

Christopher-Michael Gale

1

Publications

713

Citations

1

H-Index

0

Concepts

All Affiliations

Dana-Farber Cancer Institute
CG

About

Christopher-Michael Gale is an author at Dana-Farber Cancer Institute.

Christopher-Michael Gale

×

1

Publications

713

Citations

1

H-Index

YearCitations

PF00299804, an Irreversible Pan-ERBB Inhibitor, Is Effective in Lung Cancer Models with <i>EGFR</i> and <i>ERBB2</i> Mutations that Are Resistant to Gefitinib

Jeffrey A. Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale,

Cancer Research

2007

713

Page 1